Neogenomics Inc
NEO6.580USD
-3.390-34.00%
Cierre 04/29, 16:00（ET）Cotizaciones retrasadas 15 min
843.20MCap. mercado
PérdidaP/E TTM
Más Datos de Neogenomics Inc Compañía
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Información de la empresa
Código de la empresaNEO
Nombre de la empresaNeogenomics Inc
Fecha de salida a bolsaDec 10, 2012
Fundada en1998
Director ejecutivoMr. Antony P. Zook
Número de empleados2200
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 10
Dirección9490 Neogenomics Way
CiudadFORT MYERS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33912
Teléfono12397680600
Sitio Webhttps://neogenomics.com/
Código de la empresaNEO
Fecha de salida a bolsaDec 10, 2012
Fundada en1998
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
136.82K
+1.29%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
90.79K
-9.57%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
36.09K
--
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
11.34K
--
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
11.34K
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. Antony P. Zook
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
136.82K
+1.29%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
90.79K
-9.57%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
36.09K
--
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
11.34K
--
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
11.34K
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Clinical Services-Client direct billing
475.44M
71.98%
Clinical Services-Commercial Insurance
99.84M
15.11%
Clinical Services-Medicare and Medicaid
84.60M
12.81%
Clinical Services-Self-Pay
681.00K
0.10%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Clinical Services-Client direct billing
475.44M
71.98%
Clinical Services-Commercial Insurance
99.84M
15.11%
Clinical Services-Medicare and Medicaid
84.60M
12.81%
Clinical Services-Self-Pay
681.00K
0.10%
Accionista
Hora de actualización: jue., 20 de mar
Hora de actualización: jue., 20 de mar
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
BlackRock Institutional Trust Company, N.A.
14.49%
The Vanguard Group, Inc.
11.05%
Millennium Management LLC
5.41%
T. Rowe Price Investment Management, Inc.
5.07%
Janus Henderson Investors
4.79%
Other
59.19%
Estadísticas de accionistas
Accionista
Proporción
BlackRock Institutional Trust Company, N.A.
14.49%
The Vanguard Group, Inc.
11.05%
Millennium Management LLC
5.41%
T. Rowe Price Investment Management, Inc.
5.07%
Janus Henderson Investors
4.79%
Other
59.19%
Tipo
Accionista
Proporción
Investment Advisor/Hedge Fund
46.65%
Investment Advisor
42.43%
Hedge Fund
9.41%
Research Firm
1.68%
Pension Fund
1.08%
Individual Investor
1.06%
Bank and Trust
0.57%
Sovereign Wealth Fund
0.39%
Family Office
0.02%
Participación institucional
Hora de actualización: mar., 4 de mar
Hora de actualización: mar., 4 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
568
133.27M
103.75%
-2.98M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
2022Q4
717
116.51M
92.28%
-28.70M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
18.64M
14.51%
+221.10K
+1.20%
Dec 31, 2024
The Vanguard Group, Inc.
14.21M
11.06%
+192.25K
+1.37%
Dec 31, 2024
Millennium Management LLC
6.95M
5.41%
+5.53M
+387.74%
Mar 13, 2025
T. Rowe Price Investment Management, Inc.
6.53M
5.08%
-13.29K
-0.20%
Dec 31, 2024
Janus Henderson Investors
6.17M
4.8%
-438.12K
-6.63%
Dec 31, 2024
Brown Advisory
6.16M
4.79%
-733.08K
-10.64%
Dec 31, 2024
State Street Global Advisors (US)
5.20M
4.05%
+239.91K
+4.84%
Dec 31, 2024
Greenhouse Funds LLLP
4.70M
3.66%
+237.49K
+5.32%
Dec 31, 2024
Macquarie Investment Management
3.81M
2.97%
-12.39K
-0.32%
Dec 31, 2024
Schroder Investment Management North America Inc.
3.80M
2.96%
-419.61K
-9.94%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
SPDR S&P Health Care Services ETF
1.66%
WisdomTree BioRevolution Fund
0.85%
Invesco S&P SmallCap Health Care ETF
0.76%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.51%
First Trust Small Cap Growth AlphaDEX Fund
0.22%
OneAscent Small Cap Core ETF
0.2%
iShares U.S. Healthcare Providers ETF
0.19%
Inspire Small/Mid Cap ESG ETF
0.12%
First Trust Small Cap Core Alphadex Fund
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.11%
Ver más
SPDR S&P Health Care Services ETF
Proporción1.66%
WisdomTree BioRevolution Fund
Proporción0.85%
Invesco S&P SmallCap Health Care ETF
Proporción0.76%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.51%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.22%
OneAscent Small Cap Core ETF
Proporción0.2%
iShares U.S. Healthcare Providers ETF
Proporción0.19%
Inspire Small/Mid Cap ESG ETF
Proporción0.12%
First Trust Small Cap Core Alphadex Fund
Proporción0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.11%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos